This study provides for the first time extensive and well-substantiated evidence that the expression of these receptors in pancreatic cancer can be of predictive value in the responsiveness to the direct tumour growth inhibitory effects IFN-α therapy. The gene discussed is IFNA2; the disease is pancreatic neoplasm.